{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1390296575286223232.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.3400/avd.cr.23-00010"}},{"identifier":{"@type":"URI","@value":"https://www.jstage.jst.go.jp/article/avd/16/2/16_cr.23-00010/_pdf"}},{"identifier":{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2024287129"}}],"dc:title":[{"@language":"en","@value":"Abdominal Aortic Aneurysm with Essential Thrombocythemia: A Case Report Describing Perioperative Management in Open Surgery"}],"dc:language":"en","description":[{"type":"abstract","notation":[{"@language":"en","@value":"<p>We report perioperative management and open surgery to treat a case of infrarenal abdominal aortic aneurysm with essential thrombocythemia (ET), a chronic myeloproliferative disorder associated with arterial or venous thrombosis, idiopathic bleeding, and heparin-resistant diathesis. Following careful preoperative management, including assessment of heparin resistance, open surgery was successfully performed to treat the aortic aneurysm of our patient. This report shows that optimal preparation for surgery is important to safely perform abdominal aortic aneurysm repair and prevent perioperative thrombosis and bleeding in patients with abdominal aortic aneurysm with ET.</p>"}],"abstractLicenseFlag":"disallow"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1410296575286223233","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Yamamoto Naoki"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Cardiovascular Surgery, Shingu Municipal Medical Center"}]},{"@id":"https://cir.nii.ac.jp/crid/1410296575286223232","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Onoda Koji"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Cardiovascular Surgery, Shingu Municipal Medical Center"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"1881641X"},{"@type":"LISSN","@value":"1881641X"},{"@type":"EISSN","@value":"18816428"}],"prism:publicationName":[{"@language":"en","@value":"Annals of Vascular Diseases"},{"@language":"en","@value":"Annals of Vascular Diseases"},{"@language":"en","@value":"Ann Vasc Dis"},{"@language":"en","@value":"AVD"}],"dc:publisher":[{"@language":"en","@value":"The Editorial Committee of Annals of Vascular Diseases"},{"@language":"ja","@value":"Annals of Vascular Diseases 編集委員会"}],"prism:publicationDate":"2023-06-25","prism:volume":"16","prism:number":"2","prism:startingPage":"150","prism:endingPage":"153"},"reviewed":"false","url":[{"@id":"https://www.jstage.jst.go.jp/article/avd/16/2/16_cr.23-00010/_pdf"},{"@id":"https://search.jamas.or.jp/link/ui/2024287129"}],"availableAt":"2023-06-25","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=abdominal%20aortic%20aneurysm","dc:title":"abdominal aortic aneurysm"},{"@id":"https://cir.nii.ac.jp/all?q=essential%20thrombocythemia","dc:title":"essential thrombocythemia"},{"@id":"https://cir.nii.ac.jp/all?q=heparin%20resistance","dc:title":"heparin resistance"},{"@id":"https://cir.nii.ac.jp/all?q=abdominal%20aortic%20aneurysm","dc:title":"abdominal aortic aneurysm"},{"@id":"https://cir.nii.ac.jp/all?q=essential%20thrombocythemia","dc:title":"essential thrombocythemia"},{"@id":"https://cir.nii.ac.jp/all?q=heparin%20resistance","dc:title":"heparin resistance"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360016868142337408","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Percutaneous coronary intervention in a patient with heparin resistance due to essential thrombocythaemia: a case report"}]},{"@id":"https://cir.nii.ac.jp/crid/1360016870120777344","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019"}]},{"@id":"https://cir.nii.ac.jp/crid/1360016870448128000","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Platelet-activating anti-PF4 disorders: An overview"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298344775707648","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A Standardized Bolus of 5 000 IU of Heparin Does not Lead to Adequate Heparinization during Non-cardiac Arterial Procedures"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574096585426176","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Coagulation, fibrinolysis, and platelet activation in patients undergoing open and endovascular repair of abdominal aortic aneurysm"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579818543303552","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Resolution of Platelet-Rich Thrombi in Essential Thrombocythemia: Mechanisms, Risks, and Benefits of Antiplatelet Therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861294699912320","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Heparin Resistance — Clinical Perspectives and Management Strategies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861294963041408","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Weight Based Heparin Dosage with Activated Clotting Time Monitoring Leads to Adequate and Safe Anticoagulation in Non-Cardiac Arterial Procedures"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418862983424","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419974985984","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia"}]}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:2010694463"},{"@type":"CROSSREF","@value":"10.3400/avd.cr.23-00010"}]}